Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
27
RLMD Quote, Financials, Valuation and Earnings
Last price:
$0.36
Seasonality move
:
8.98%
Day range:
$0.34 - $0.38
52-week range:
$0.34 - $7.22
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.23x
Volume:
424K
Avg. volume:
1.5M
1-year change:
-85.18%
Market cap:
$11M
Revenue:
--
EPS (TTM):
-$2.86
Earnings Data
Next earnings date for RLMD
Mar 19
2025
Most recent earnings per share
-$0.72
Missed by $0.72
(Nov 7/2024)
Consensus Estimate
--
(Nov 7/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RLMD Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/19/2025 | Q4 | -- | -- | -- | -- | -- |
| 11/07/2024 | Q3 | -- | -- | -$0.72 | -- | -- |
| 08/07/2024 | Q2 | -- | -- | -$0.59 | -- | -- |
| 05/08/2024 | Q1 | -- | -- | -$0.72 | -- | -- |
| 03/19/2024 | Q4 | -- | -- | -$0.83 | -- | -- |
| 11/08/2023 | Q3 | -- | -- | -$0.73 | -- | -- |
| 08/08/2023 | Q2 | -- | -- | -$0.84 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | -$0.87 | -- | -- |
| 03/23/2023 | Q4 | -- | -- | -$1.26 | -- | -- |
| 11/10/2022 | Q3 | -- | -- | -$1.31 | -$1.47 | $0.16 |
| 08/11/2022 | Q2 | -- | -- | -$1.33 | -$1.32 | -$0.01 |
| 05/05/2022 | Q1 | -- | -- | -$1.40 | -$1.22 | -$0.18 |
| 03/23/2022 | Q4 | -- | -- | -$1.80 | -$1.88 | $0.08 |
| 11/11/2021 | Q3 | -- | -- | -$2.44 | -$1.55 | -$0.89 |
| 08/10/2021 | Q2 | -- | -- | -$1.56 | -$1.47 | -$0.09 |
| 05/12/2021 | Q1 | -- | -- | -$1.34 | -$1.42 | $0.08 |
| 03/23/2021 | Q4 | -- | -- | -$1.29 | -$1.31 | $0.01 |
| 11/12/2020 | Q3 | -- | -- | -$1.05 | -$0.94 | -$0.11 |
| 08/12/2020 | Q2 | -- | -- | -$0.73 | -$0.63 | -$0.11 |
| 05/15/2020 | Q1 | -- | -- | -$0.72 | -$0.37 | -$0.35 |
| 12/31/2019 | Q4 | -- | -- | -$0.39 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.38 | -- | -- |
Relmada Therapeutics Earnings Questions
-
How Much did Relmada Therapeutics Generate in Revenue Last Quarter?
Relmada Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Relmada Therapeutics Beat Earnings Last Quarter?
Relmada Therapeutics announced earnings per share of -$0.72 which represents a miss of analyst forecast a -- per share.
-
Is Relmada Therapeutics Profitable?
Relmada Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Relmada Therapeutics EPS Next Year?
Relmada Therapeutics's earnings are forecast to decrease from -$3.28 per share to -$1.80 per share next year representing a decrease of -39.63%.
-
When is Relmada Therapeutics's Earnings Date?
Relmada Therapeutics's next earnings date is March 19, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
